174 related articles for article (PubMed ID: 25913538)
21. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
22. Effect of sleep problems on depressive disorders 1 year after developing acute coronary syndrome: The K-DEPACS study.
Kim JM; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
J Affect Disord; 2017 Mar; 210():319-322. PubMed ID: 28073039
[TBL] [Abstract][Full Text] [Related]
23. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
24. Influences of the Big Five personality traits on the treatment response and longitudinal course of depression in patients with acute coronary syndrome: A randomised controlled trial.
Kim SY; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
J Affect Disord; 2016 Oct; 203():38-45. PubMed ID: 27280961
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effects of depression and NR3C1 methylation on prognosis of acute coronary syndrome.
Kang HJ; Stewart R; Kim JW; Kim SW; Shin IS; Kim MC; Hong YJ; Ahn Y; Shin MG; Jeong MH; Yoon JS; Kim JM
Sci Rep; 2020 Mar; 10(1):5519. PubMed ID: 32218512
[TBL] [Abstract][Full Text] [Related]
26. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
Brown ES; Howard C; Khan DA; Carmody TJ
Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular safety of one-year escitalopram therapy in clinically nondepressed patients with acute coronary syndrome: results from the DEpression in patients with Coronary ARtery Disease (DECARD) trial.
Hanash JA; Hansen BH; Hansen JF; Nielsen OW; Rasmussen A; Birket-Smith M
J Cardiovasc Pharmacol; 2012 Oct; 60(4):397-405. PubMed ID: 22820898
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
29. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
30. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
31. Increased subsequent risk of acute coronary syndrome for patients with depressive disorder: a nationwide population-based retrospective cohort study.
Lin YN; Lin CL; Chang YJ; Peng CL; Sung FC; Chang KC; Kao CH
Psychiatry Clin Neurosci; 2014 Apr; 68(4):263-9. PubMed ID: 24313756
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings.
Lyness JM; Heo M; Datto CJ; Ten Have TR; Katz IR; Drayer R; Reynolds CF; Alexopoulos GS; Bruce ML
Ann Intern Med; 2006 Apr; 144(7):496-504. PubMed ID: 16585663
[TBL] [Abstract][Full Text] [Related]
33. Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct.
Kim S; Woo SY; Kang HS; Lim SW; Choi SH; Myung W; Jeong JH; Lee Y; Hong CH; Kim JH; Na H; Carroll BJ; Kim DK
Int J Geriatr Psychiatry; 2016 Jul; 31(7):818-26. PubMed ID: 26679895
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for incident depression in patients at first acute coronary syndrome.
Ossola P; Paglia F; Pelosi A; De Panfilis C; Conte G; Tonna M; Ardissino D; Marchesi C
Psychiatry Res; 2015 Aug; 228(3):448-53. PubMed ID: 26144582
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.
Phillips KA; Keshaviah A; Dougherty DD; Stout RL; Menard W; Wilhelm S
Am J Psychiatry; 2016 Sep; 173(9):887-95. PubMed ID: 27056606
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
Llorca PM; Azorin JM; Despiegel N; Verpillat P
Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
[TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
[TBL] [Abstract][Full Text] [Related]
38. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
39. Persistence of posttraumatic stress symptoms 12 and 36 months after acute coronary syndrome.
Wikman A; Bhattacharyya M; Perkins-Porras L; Steptoe A
Psychosom Med; 2008 Sep; 70(7):764-72. PubMed ID: 18725431
[TBL] [Abstract][Full Text] [Related]
40. Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.
Foss-Nieradko B; Stepnowska M; Piotrowicz R
Kardiol Pol; 2012; 70(6):591-7. PubMed ID: 22718378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
